
For the year ended Dec 2018, Procter & Gamble Health reported revenue of ₹849 crore and net profit of ₹839 crore, against ₹1,009 crore and ₹177 crore a year earlier.
Financial years, newest first. TTM = trailing twelve months.
| Item | Dec 2018 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Revenue | 849 | 1,009 | 1,092 | 1,206 | 1,129 | 1,385 | 1,433 |
| Expenses | 702 | 763 | 817 | 882 | 823 | 927 | 967 |
| Operating profit | 147 | 246 | 275 | 324 | 307 | 459 | 466 |
| Operating margin % | 17% | 24% | 25% | 27% | 27% | 33% | 33% |
| Other income | 31 | 18 | 6 | 19 | -5 | 15 | 49 |
| Interest | 0 | 1 | 0 | 1 | 1 | 1 | 1 |
| Depreciation | 20 | 30 | 27 | 28 | 27 | 24 | 24 |
| Profit before tax | 158 | 233 | 253 | 314 | 273 | 450 | 490 |
| Tax % | 36% | 24% | 24% | 27% | 26% | 27% | 27% |
| Net profit | 839 | 177 | 193 | 229 | 201 | 327 | 357 |
| EPS (₹) | 0.00 | 106.51 | 115.98 | 138.24 | 121.08 | 196.94 | 215.00 |
| Dividend payout % | — | — | — | — | — | — | — |
Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.
For the financial year ended Dec 2018, Procter & Gamble Health's revenue was ₹849 crore and net profit ₹839 crore; net profit rose 374.01% from ₹177 crore in Jun 2021.
From Jun 2023 to Dec 2018, Procter & Gamble Health's revenue grew at a compound annual rate of -11.0% and net profit at 54.2%. Past growth does not indicate future results.
Annual EPS for Dec 2018 was ₹0.00.
They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.
Track PGHL live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.